- 专利标题: Hypoxic NK cells and methods therefor
-
申请号: US16491559申请日: 2018-03-07
-
公开(公告)号: US11221328B2公开(公告)日: 2022-01-11
- 发明人: Patrick Soon-Shiong , Shahrooz Rabizadeh , Kayvan Niazi , Stephen Charles Benz , Laurent H. Boissel , Hans Klingemann , Barry J. Simon
- 申请人: NANTCELL, INC.
- 申请人地址: US CA Culver City
- 专利权人: NANTCELL, INC.
- 当前专利权人: NANTCELL, INC.
- 当前专利权人地址: US CA Culver City
- 代理机构: Umberg Zipser LLP
- 代理商 Martin Fessenmaier
- 国际申请: PCT/US2018/021303 WO 20180307
- 国际公布: WO2018/165265 WO 20180913
- 主分类号: C12Q1/6886
- IPC分类号: C12Q1/6886 ; G01N33/50 ; G16H50/30 ; C12N5/0783
摘要:
Detection of under-expression of selected genes in NK cells is used to confirm a hypoxic tumor microenvironment that is ordinarily suppressive with respect to ADCC and cytotoxic cell killing of NK cells. Most notably, while hypoxia is known to upregulate HIF-1α and genes under the control of HIF-1α, hypoxia in a tumor microenvironment led to under-expression of selected genes, including HIF-1α. Thus, gene expression analysis of certain genes on NK cells can be used to detect conditions in a tumor that would indicate use of haNK cells.
公开/授权文献
- US20200041490A1 HYPOXIC NK CELLS AND METHODS THEREFOR 公开/授权日:2020-02-06
信息查询
IPC分类: